JIM YOUSSEF

Allopathic & Osteopathic Physicians|Orthopaedic Surgery|Orthopaedic Surgery of the Spine DURANGO, CO NPI 1154373850

General Payments — all program years on this page

$2,613,403.75

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 531
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $24,704.64 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Royalty or License $23,940.6612
Food and Beverage $463.985
Consulting Fee $300.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Globus Medical, Inc. $23,706.6911
CTL Medical Corporation $533.972
Augmedics Inc. $208.171
MML US, Inc. $140.142
Curiteva, Inc. $93.161
Kuros Biosciences USA, Inc $22.511

By program year

Program yearAmountRecords
2018 $340,525.7990
2019 $1,087,898.90121
2020 $323,855.1360
2021 $310,212.64104
2022 $358,557.09106
2023 $167,649.5632
2024 $24,704.6418

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1075872914 CTL Medical Corporation $514.84 01/29/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1075872917 CTL Medical Corporation $19.13 04/12/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1091175946 Curiteva, Inc. $93.16 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139159373 Kuros Biosciences USA, Inc $22.51 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140892702 Augmedics Inc. $208.17 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145000496 Globus Medical, Inc. $5,798.69 02/14/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1145000508 Globus Medical, Inc. $2,153.00 11/15/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1145000510 Globus Medical, Inc. $2,062.00 11/15/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1145000512 Globus Medical, Inc. $1,848.00 11/15/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1145000520 Globus Medical, Inc. $2,414.00 08/20/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1145000522 Globus Medical, Inc. $1,741.00 08/20/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1145000524 Globus Medical, Inc. $1,393.00 08/20/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1145000532 Globus Medical, Inc. $2,525.00 05/21/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1145000534 Globus Medical, Inc. $1,682.00 05/21/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1145000536 Globus Medical, Inc. $1,790.00 05/21/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1145000600 Globus Medical, Inc. $300.00 06/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1152306155 MML US, Inc. $109.93 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152306157 MML US, Inc. $30.21 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.